An exploratory study of factors influencing glaucoma treatment adherence
- PMID: 20075676
- PMCID: PMC2808197
- DOI: 10.1097/IJG.0b013e31819c4679
An exploratory study of factors influencing glaucoma treatment adherence
Abstract
Purpose: To understand the factors that influence glaucoma treatment adherence with medication taking, prescription refills, and appointment keeping to develop an intervention for a specific population.
Patients and methods: In-depth interviews were conducted with 80 individuals diagnosed with open-angle glaucoma, glaucoma suspect, or ocular hypertension. Additional eligibility requirements were that all participants were: between the ages of 18 to 80; white or African American; spoke and understood English; and were taking daily doses of topical glaucoma treatments for at least the past year. Cross-tabulations and chi2 tests were conducted to compare adherent and nonadherent individuals, classified as such based on self-report and medical chart/pharmacy data.
Results: Compared with adherent participants, nonadherent participants were less likely to: believe their eye doctors spent sufficient time with them; ask their eye doctor if they had any questions; know of benefits to taking their glaucoma medication regularly; and have someone help them take their glaucoma medications or drive them to eye appointments. Conversely, compared with adherent individuals, nonadherent participants were more likely to have difficulty remembering to take their medications and to believe their glaucoma would affect their eye sight in the future.
Conclusions: Nonadherent glaucoma patients struggle with a variety of issues related to consistent use of glaucoma medicine and routine eye care. Interventions are needed to address these modifiable factors related to glaucoma treatment adherence.
Similar articles
-
Determinants of medication adherence to topical glaucoma therapy.J Glaucoma. 2012 Apr-May;21(4):234-40. doi: 10.1097/IJG.0b013e31821dac86. J Glaucoma. 2012. PMID: 21623223 Free PMC article.
-
Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.JAMA Ophthalmol. 2014 Jul;132(7):838-44. doi: 10.1001/jamaophthalmol.2014.856. JAMA Ophthalmol. 2014. PMID: 24830878
-
Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.Arch Ophthalmol. 2012 Oct;130(10):1252-8. doi: 10.1001/archophthalmol.2012.1607. Arch Ophthalmol. 2012. PMID: 22688429 Free PMC article. Clinical Trial.
-
Current and new pharmacotherapeutic approaches for glaucoma.Expert Opin Pharmacother. 2020 Nov;21(16):2027-2040. doi: 10.1080/14656566.2020.1795130. Epub 2020 Jul 27. Expert Opin Pharmacother. 2020. PMID: 32717157 Review.
-
Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Drugs Aging. 2015 Jul;32(7):569-81. doi: 10.1007/s40266-015-0282-9. Drugs Aging. 2015. PMID: 26136215 Review.
Cited by
-
Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.Jpn J Ophthalmol. 2013 Jan;57(1):47-56. doi: 10.1007/s10384-012-0188-6. Epub 2012 Oct 12. Jpn J Ophthalmol. 2013. PMID: 23065047 Clinical Trial.
-
The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma.Optom Vis Sci. 2018 Feb;95(2):155-162. doi: 10.1097/OPX.0000000000001173. Optom Vis Sci. 2018. PMID: 29370021 Free PMC article. Review.
-
The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.Ophthalmology. 2015 Jul;122(7):1308-16. doi: 10.1016/j.ophtha.2015.03.026. Epub 2015 Apr 24. Ophthalmology. 2015. PMID: 25912144 Free PMC article.
-
Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research.Pharmaceutics. 2021 Jul 20;13(7):1100. doi: 10.3390/pharmaceutics13071100. Pharmaceutics. 2021. PMID: 34371791 Free PMC article.
-
Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients.Patient Educ Couns. 2015 Jul 6:S0738-3991(15)30010-0 10.1016/j.pec.2015.07.001. doi: 10.1016/j.pec.2015.07.001. Online ahead of print. Patient Educ Couns. 2015. PMID: 26223851 Free PMC article.
References
-
- Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(8):1439–48. [see comment] - PubMed
-
- Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. American Journal of Ophthalmology. 1998;126(4):487–97. [see comment][erratum appears in Am J Ophthalmol 1999 Jan;127(1):120] - PubMed
-
- Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–716. - PubMed
-
- The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. American Journal of Ophthalmology. 2000;130(4):429–40. [see comment] - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous